Taiwan
· Delayed Price · Currency is TWD TTY Biopharm Company Statistics
Total Valuation
TTY Biopharm Company has a market cap or net worth of TWD 18.20 billion. The enterprise value is 18.47 billion.
| Market Cap | 18.20B |
| Enterprise Value | 18.47B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Mar 28, 2024 |
Share Statistics
TTY Biopharm Company has 248.65 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 248.65M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 11.44% |
| Owned by Institutions (%) | 15.97% |
| Float | 193.63M |
Valuation Ratios
The trailing PE ratio is 16.23.
| PE Ratio | 16.23 |
| Forward PE | n/a |
| PS Ratio | 3.18 |
| PB Ratio | 3.13 |
| P/FCF Ratio | 18.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.79, with an EV/FCF ratio of 18.53.
| EV / Earnings | 16.44 |
| EV / Sales | 3.23 |
| EV / EBITDA | 10.79 |
| EV / EBIT | 12.06 |
| EV / FCF | 18.53 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 37.00.
| Current Ratio | 1.85 |
| Quick Ratio | 1.41 |
| Debt / Equity | 37.00 |
| Debt / EBITDA | 1.54 |
| Debt / FCF | 2.42 |
| Interest Coverage | 38.36 |
Financial Efficiency
Return on equity (ROE) is 18.29% and return on invested capital (ROIC) is 10.05%.
| Return on Equity (ROE) | 18.29% |
| Return on Assets (ROA) | 8.71% |
| Return on Capital (ROIC) | 10.05% |
| Revenue Per Employee | 16.74M |
| Profits Per Employee | 3.29M |
| Employee Count | 342 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.43% in the last 52 weeks. The beta is 0.20, so TTY Biopharm Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -3.43% |
| 50-Day Moving Average | 74.43 |
| 200-Day Moving Average | 77.98 |
| Relative Strength Index (RSI) | 40.81 |
| Average Volume (20 Days) | 272,131 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TTY Biopharm Company had revenue of TWD 5.73 billion and earned 1.12 billion in profits. Earnings per share was 4.51.
| Revenue | 5.73B |
| Gross Profit | 3.40B |
| Operating Income | 1.39B |
| Pretax Income | 1.45B |
| Net Income | 1.12B |
| EBITDA | 1.57B |
| EBIT | 1.39B |
| Earnings Per Share (EPS) | 4.51 |
Balance Sheet
The company has 2.85 billion in cash and 2.41 billion in debt, giving a net cash position of 437.57 million or 1.76 per share.
| Cash & Cash Equivalents | 2.85B |
| Total Debt | 2.41B |
| Net Cash | 437.57M |
| Net Cash Per Share | 1.76 |
| Equity (Book Value) | 6.51B |
| Book Value Per Share | 23.35 |
| Working Capital | 2.55B |
Cash Flow
In the last 12 months, operating cash flow was 1.09 billion and capital expenditures -90.71 million, giving a free cash flow of 996.34 million.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -90.71M |
| Free Cash Flow | 996.34M |
| FCF Per Share | 4.01 |
Margins
Gross margin is 59.34%, with operating and profit margins of 24.20% and 19.62%.
| Gross Margin | 59.34% |
| Operating Margin | 24.20% |
| Pretax Margin | 25.33% |
| Profit Margin | 19.62% |
| EBITDA Margin | 27.36% |
| EBIT Margin | 24.20% |
| FCF Margin | 17.40% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.76%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 4.76% |
| Dividend Growth (YoY) | -45.31% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 77.45% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 4.72% |
| Earnings Yield | 6.16% |
| FCF Yield | 5.47% |
Stock Splits
The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.
| Last Split Date | Aug 13, 2014 |
| Split Type | Forward |
| Split Ratio | 1.067 |